Contributor Page
Krishna & Saurastri Associates
Email  |  Articles
Contact Details
Tel: +91 124 4114208
Fax: +91 124 4114210
407, Global Foyer, 4th Floor
Golf Course Road
Sector 43
By Krishna & Saurastri Associates
Recently, the Hon'ble Bombay High Court in People Interactive (I) Pvt. Ltd. vs. Gaurav Jerry and Ors., dealt extensively with use of trade mark in meta-tags for the first time...
By Krishna & Saurastri Associates
Recently, Clause No. 3 of a notification issued by the Controller of Patents, Designs and Trade Marks...
By R. Muralidharan, Ashima Katara
Pharmaceutical giant Bayer filed an appeal against the granting of a compulsory licence for Nexavar to Indian generic manufacturer Natco...
By Richa Pandey
How long back would you have to look if you wanted to find the link between patents and politics? Probably at the very inception of patents.
By Krishna & Saurastri Associates
When an application for a patent is made at the Indian Patent office ("IPO") by virtue of an assignment of the right to apply, the IPO requires the submission of the proof of right.
By Krishna & Saurastri Associates
Hyderabad Trial Court, on September 26, 2014, denied an interim injunction to Bristol-Myers Squibb (BMS) in a suit against Mylan regarding the export of HIV Drug Atazanavir to Venezuela.
By Krishna & Saurastri Associates
When we foray into the world of pharmaceutical patents, many contentions raise their heads. Once the product patent regime came into force in India, the road ahead seemed fraught with difficulties.
By Krishna & Saurastri Associates
The Plaintiff is a French company and the Defendant No.1 is an Israeli company having its office in Mumbai and the Defendant No.2 is a majority shareholder of the Defendant No.1.